Global public health decision-makers emphasize that the epidemiological situation related to the increasing incidence of Clostridioides difficile infections requires continuous attention and action. This is particularly important because currently used treatments for patients with C. difficile infection are not always effective. Hopefully, the results of my research can help develop new therapeutic strategies in the future to support treatment and prevent recurrent infections caused by this pathogen, writes Piotr Lalowski, MSc Eng, a PhD student from the Chair and Department of Medical Microbiology at the Medical University of Warsaw.

